Bulletin
Investor Alert

April 2, 2020, 8:40 a.m. EDT

CBD Sales Spike Prior To Shelter-In-Place Orders, But Its Staying Power Now Is Not As A Coronavirus Cure But As A Reducer Of Anxiety And Stress

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Procter & Gamble Co. (PG)
  • X
    3M Co. (MMM)

or Cancel Already have a watchlist? Log In

Apr 02, 2020 (Stock Market Press via COMTEX) -- More states, such as Florida, issued coronavirus related stay-at-home orders yesterday (April 1, 2020). CBD is not a cure for COVID-19, but it offers relief from anxiety and stress by people who fear they, family or friends may contract it. As a result, we have seen CBD products show staying power in sales during the crisis -- selling online, in dispensaries and other licensed retailers deemed essential businesses by state and local authorities.

The global impact of the coronavirus has intensified coverage of companies that market CBD and other health-related products. Media firms such as stockmarketpress.com feature coverage of CBD and health-related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Johnson & Johnson (NASDAQ: JNJ), Procter & Gamble /zigman2/quotes/202894679/composite PG +1.96% , Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) and OrganiGram Holdings Inc. (NASDAQ: OGI).

CBD Sales Spiked Prior To Shelter-In-Place Orders, But Its Staying Power Now Is Not As A Coronavirus Cure But As A Reducer Of Anxiety And Stress

CBD is not a cure or protocol for medically treating the coronavirus but its properties address key elements. It is known to offer anti-viral, anti-inflammatory and anti-bacterial properties. It also acts as an effective treatment for nausea and vomiting, which can be induced by the coronavirus in humans. Just as important, CBD can be a relaxant for anxiety and stress of home-bound people fearful of catching the virus. CBD sales spiked prior to shelter-in-place orders, but its staying power now is not as a coronavirus cure but as a reducer of anxiety and stress.

Nationwide online sales of CBD jumped 230% prior to the coronavirus quarantines and in California orders hit a record peak after Gov. Gavin Newsom issued his shelter-in-place order for the state, the Wall Street Journal reported, based on data from website Weedmaps. As more states mandate stay-at-home orders with only essential travel permitted (visits to groceries and pharmacies), several states have ruled that CBD dispensaries and licensing shops are essential and can remain open during the crisis. CBD sales spiked prior to shelter-in-place orders, but its staying power now is not as a coronavirus cure but as a reducer of anxiety and stress.

As a result, CBD is playing an important role in calming the nerves of shut-ins. The conclusion of the record online sales and spike in California sales the day that state issued a mandatory stay-at-home order is that CBD and cannabis customers stocked up on product prior to being home-bound during the coronavirus crisis. We have seen runs on hand sanitizer and toilet paper. CBD and cannabis remained available at legal and licensed retailers, several states ruled. It is also available online, where traditionally 70% of CBD sales are made. CBD sales spiked prior to shelter-in-place orders, but its staying power now is not as a coronavirus cure but as a reducer of anxiety and stress.

CBD Unlimited, Inc.'s (OTC PINK: EDXC) Sees Growth In CBD Future

As it excels in this environment, CBD Unlimited, Inc. (OTC PINK: EDXC) is continuing to remain aggressive in marketing product. CBD has an important role to play for shelter-at-home consumers and if they desire CBD they can buy it to calm their nerves during these unprecedented times. They can buy CBD Unlimited, Inc.'s (OTC PINK: EDXC) product online at its own website from remote home locations or in pharmacies, such as in many Walgreen's, or other mass market retail locations that remain open.

CBD Sales May Be Increasing During The Coronavirus Pandemic As Consumers Stock Up

CBD Unlimited, Inc.'s (OTC PINK: EDXC) high quality product, a healthy alternative for home-bound consumers, is important for consumers who see general health as especially significant today. Just as they seek personal purification from hand sanitizer to prevent coronavirus, they want quality in all foods they ingest. CBD is also seen globally as a product which needs to be top quality and healthy for the body.

In response to the crisis, a number of companies are manufacturing and marketing hand sanitizer and health-related sanitizing products. These include: Gojo Industries, Inc., which is privately held and makes Purell; Procter & Gamble /zigman2/quotes/202894679/composite PG +1.96% ; 3M /zigman2/quotes/205029460/composite MMM +2.99% ; Ecolab /zigman2/quotes/202628210/composite ECL +3.41% , Unilever Group (NYSE: UN) and Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.39% . Some boutique liquor manufacturers are using their alcohol materials to manufacture hand sanitizer. That product is making onto supermarket shelves, such as Stew Leonard's on the East Coast in Connecticut and New York.

CBD Unlimited, Inc. (otc pink:EDXC) Reports 101% Annual Increase

Recently, Todd Davis, CEO of CBD Unlimited, Inc. (otc pink:EDXC), said the company had a record performance in Q2 and discussed it in an update interview with NASDAQ MarketSite. The full interview will be released on April 6, Davis said. The company had reported growth in full year 2019 with a 101% annual increase in revenues over the prior year. Davis said CBD Unlimited, Inc. (otc pink:EDXC) is 'on track' to meet its upward growth trajectory and surpass YOY guidance and goals. A reason for that is omni-channel marketing from this company that is innovative and aggressive.

CBD Unlimited, Inc. (otc pink:EDXC) Uses Seed-To-Shelf Strategy To Achieve Quality Control

CBD Unlimited, Inc. (OTC PINK: EDXC) ensures its CBD products are highest quality, American-manufactured and tightly controlled by a corporate seed-to-shelf manufacturing strategy. Its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent Corporate Presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. Product is cGMP Certified (Good Manufacturing Practice Certification).

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press

COMTEX_364118545/2617/2020-04-02T08:39:45

/zigman2/quotes/202894679/composite
US : U.S.: NYSE
$ 118.33
+2.28 +1.96%
Volume: 7.34M
June 5, 2020 4:00p
P/E Ratio
66.87
Dividend Yield
2.67%
Market Cap
$287.30 billion
Rev. per Employee
$727,304
loading...
/zigman2/quotes/202894679/composite
US : U.S.: NYSE
$ 118.33
+2.28 +1.96%
Volume: 7.34M
June 5, 2020 4:00p
P/E Ratio
66.87
Dividend Yield
2.67%
Market Cap
$287.30 billion
Rev. per Employee
$727,304
loading...
/zigman2/quotes/205029460/composite
US : U.S.: NYSE
$ 167.41
+4.86 +2.99%
Volume: 4.53M
June 5, 2020 4:00p
P/E Ratio
19.65
Dividend Yield
3.51%
Market Cap
$93.50 billion
Rev. per Employee
$350,368
loading...
/zigman2/quotes/202628210/composite
US : U.S.: NYSE
$ 229.56
+7.56 +3.41%
Volume: 14.13M
June 5, 2020 4:00p
P/E Ratio
43.44
Dividend Yield
0.82%
Market Cap
$64.20 billion
Rev. per Employee
$299,351
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 147.30
+0.57 +0.39%
Volume: 9.73M
June 5, 2020 4:00p
P/E Ratio
22.97
Dividend Yield
2.74%
Market Cap
$386.57 billion
Rev. per Employee
$603,509
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.